Filing Details
- Accession Number:
- 0001237899-21-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-24 16:06:03
- Reporting Period:
- 2021-08-20
- Accepted Time:
- 2021-08-24 16:06:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238303 | J Joseph Larosa | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp General Counsel And Secret | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-20 | 10,000 | $179.13 | 23,182 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-20 | 6,575 | $664.85 | 16,607 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-08-23 | 3,383 | $661.80 | 13,224 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-23 | 41 | $665.40 | 13,183 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-23 | 1 | $666.22 | 13,182 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-20 | 10,000 | $0.00 | 10,000 | $179.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2022-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,186 | Indirect | 2021 GRAT |
| Common Stock | 314 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 41 shares of Company stock on August 23, 2021 at prices ranging from $665.21 to $665.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
